Health & Fitness
Wed, May 12, 2010Tue, May 11, 2010Mon, May 10, 2010Sun, May 9, 2010Sat, May 8, 2010Fri, May 7, 2010Thu, May 6, 2010Mon, January 11, 2010Sat, January 9, 2010Fri, January 8, 2010Thu, January 7, 2010Wed, January 6, 2010Tue, January 5, 2010Mon, January 4, 2010Thu, December 31, 2009Wed, December 30, 2009Tue, December 29, 2009Mon, December 28, 2009Thu, December 24, 2009Wed, December 23, 2009Urologix, Inc. to Present at OneMedForum 2010
Published in Health and Fitness on Saturday, January 9th 2010 at 10:15 GMT by Market Wire
MINNEAPOLIS--([ BUSINESS WIRE ])--Urologix®, Inc. (NASDAQ:ULGX), announced today Stryker Warren Jr., Chief Executive Officer, is scheduled to present at the OneMedForum 2010 Emerging Company Finance Conference on Tuesday, January 12, 2010 at 2:30 p.m. PT in San Francisco. Mr. Warren will provide an overview of the Company and an update on its minimally invasive Cooled ThermoTherapy™ treatment that provides a durable and effective procedure which for many men is an alternative to drugs or surgery. This minimally invasive therapy is delivered in the comfort of the urologist's office for patients suffering from an enlarged prostate, also known as benign prostatic hyperplasia (BPH).
About Urologix
Urologix, Inc., based in Minneapolis, develops, manufactures and markets minimally invasive medical products for the treatment of urological disorders. The Company has developed and offers non-surgical, anesthesia-free, catheter-based treatments that use a proprietary cooled microwave technology for the treatment of benign prostatic hyperplasia (BPH), a condition that affects more than 23 million men worldwide. Urologix' products include the CoolWave® , Targis® and Prostatron® control units and the CTC Advance™, Cooled ThermoCath® , Targis® and Prostaprobe® catheter families. All of Urologix' products utilize Cooled ThermoTherapy™ - targeted microwave energy combined with a unique cooling mechanism to protect healthy tissue and enhance patient comfort - and provide safe, effective, lasting relief of the symptoms of BPH.
Forward Looking Statements
This press release contains forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any statements contained in this press release that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the foregoing, words such as "may," "will," "expect," "believe," "anticipate," "estimate" or "continue" or comparable terminology are intended to identify forward-looking statements. Such forward looking statements include, for example, statements about the Company's working capital and capital resource needs and future revenue and operating performance, statements about the Company's ability to develop and market new products, and statements about the Company-owned Cooled ThermoTherapy mobile service. The statements made by the Company are based upon management's current expectations and are subject to certain risks and uncertainties that could cause the actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include market conditions and other factors beyond the Company's control and the risk factors and other cautionary statements described in the Company's Annual Report on Form 10-K for the year ended June 30, 2009 and other documents filed with the Securities and Exchange Commission.
